BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8655594)

  • 1. Deletion of specific protein kinase C subspecies in human melanoma cells.
    Oka M; Ogita K; Ando H; Horikawa T; Hayashibe K; Saito N; Kikkawa U; Ichihashi M
    J Cell Physiol; 1996 Jun; 167(3):406-12. PubMed ID: 8655594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential down-regulation of protein kinase C subspecies in normal human melanocytes: possible involvement of the zeta subspecies in growth regulation.
    Oka M; Ogita K; Ando H; Kikkawa U; Ichihashi M
    J Invest Dermatol; 1995 Oct; 105(4):567-71. PubMed ID: 7561160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation.
    Arita Y; O'Driscoll KR; Weinstein IB
    Cancer Res; 1992 Aug; 52(16):4514-21. PubMed ID: 1643643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C beta expression in melanoma cells and melanocytes: differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetate.
    Powell MB; Rosenberg RK; Graham MJ; Birch ML; Yamanishi DT; Buckmeier JA; Meyskens FL
    J Cancer Res Clin Oncol; 1993; 119(4):199-206. PubMed ID: 7678596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells.
    Krasagakis K; Fimmel S; Genten D; Eberle J; Quas P; Ziegler W; Haller H; Orfanos CE
    Int J Oncol; 2002 Apr; 20(4):865-71. PubMed ID: 11894137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas.
    Yamanishi DT; Graham M; Buckmeier JA; Meyskens FL
    Carcinogenesis; 1991 Jan; 12(1):105-9. PubMed ID: 1988168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13-acetate.
    Arita Y; O'Driscoll KR; Weinstein IB
    Int J Cancer; 1994 Jan; 56(2):229-35. PubMed ID: 8314307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
    Stanwell C; Gescher A; Bradshaw TD; Pettit GR
    Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure of normal human melanocytes to a tumor promoting phorbol ester reverses growth suppression by transforming growth factor beta.
    Stavroulaki M; Kardassis D; Chatzaki E; Sakellaris G; Lindschau C; Haller H; Tosca A; Krasagakis K
    J Cell Physiol; 2008 Feb; 214(2):363-70. PubMed ID: 17654516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas.
    Becker D; Beebe SJ; Herlyn M
    Oncogene; 1990 Aug; 5(8):1133-9. PubMed ID: 2392322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual regulation of phospholipase D1 by protein kinase C alpha in vivo.
    Oka M; Hitomi T; Okada T; Nakamura Si S; Nagai H; Ohba M; Kuroki T; Kikkawa U; Ichihashi M
    Biochem Biophys Res Commun; 2002 Jun; 294(5):1109-13. PubMed ID: 12074591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage.
    Selzer E; Okamoto I; Lucas T; Kodym R; Pehamberger H; Jansen B
    Melanoma Res; 2002 Jun; 12(3):201-9. PubMed ID: 12140376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies.
    Watanabe T; Ono Y; Taniyama Y; Hazama K; Igarashi K; Ogita K; Kikkawa U; Nishizuka Y
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10159-63. PubMed ID: 1438205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of melanocytic cells is associated with down-regulation of protein kinase C alpha, delta, and epsilon isoforms. Possible role of diacylglycerol.
    Brooks G; Goss MW; East JA; Hart IR
    J Biol Chem; 1993 Nov; 268(32):23868-75. PubMed ID: 8226926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.
    Powell CT; Brittis NJ; Stec D; Hug H; Heston WD; Fair WR
    Cell Growth Differ; 1996 Apr; 7(4):419-28. PubMed ID: 9052983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth.
    Brooks G; Wilson RE; Dooley TP; Goss MW; Hart IR
    Cancer Res; 1991 Jun; 51(12):3281-8. PubMed ID: 2040003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
    Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
    Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?
    Gilhooly EM; Morse-Gaudio M; Bianchi L; Reinhart L; Rose DP; Connolly JM; Reed JA; Albino AP
    Melanoma Res; 2001 Aug; 11(4):355-69. PubMed ID: 11479424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
    Drew L; Groome N; Warr JR; Rumsby MG
    Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.